CTIC — CTI Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid Cap

Annual balance sheet for CTI Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	67	33.7	52.5	65.4	79.9
Net Total Accounts Receivable
Net Total Receivables	13.7	0	—	—	15.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	82.5	35.6	54.3	68.4	99.4
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.79	4.61	2.87	3.29	2.08
Net Intangible Assets
Other Long Term Assets
Total Assets	89.8	46.3	58.2	72.4	126
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	23.1	18.5	17	66.7	81.1
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	31.1	22.6	18.2	68.7	144
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	58.7	23.7	40	3.77	-17.6
Total Liabilities & Shareholders' Equity	89.8	46.3	58.2	72.4	126
Total Common Shares Outstanding
Total Preferred Shares Outstanding